TD Cowen lowered the firm’s price target on Avantor (AVTR) to $28 from $31 and keeps a Buy rating on the shares. The firm said Q3 was better than expected save for the significant weakness in Semis. Bioprocess looked good, Lab saw modest improvement with strong cost out and FCF.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: